Tony Yu
Vermogen: 456 603 $ op 31-05-2026
Vermogen: 456 603 $ op 31-05-2026
Tony Yu currently holds the position of Chief Scientific Officer at Genelux Corp.
since 2026 and is a Member of the American Society of Clinical Oncology, Inc. Education history includes an undergraduate degree from the University of Utah and a doctorate from Loma Linda University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GENELUX CORP. 0,33% | 11-05-2026 | 149.706 ( 0,33% ) | 456 603 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GENELUX CORPORATION | Hoofd Techniek/Wetenschap/O&O | 01-05-2026 |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Genelux Corp.
Genelux Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs and virus strains solutions | Health Technology |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loma Linda University
Loma Linda University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau